Abstract
Research has stated that innovativeness is a key element in biotechnology firms where support from the top management (TMS) and team innovation orientation (TMI) shape the development of the innovative process in the firms. The current study explores biotechnology firms’ (INN) innovativeness in firm growth (FG) in Malaysia. The study included and empirically tested two moderators, the role of TMS and TMI. Questionnaires were used to obtain a sample of 125 biotechnology firms. A survey was dispensed to three to four employees with three or more years of experience in managerial positions. A sample of 215 complete responses was utilized for SEM analysis. The findings revealed that innovativeness in biotechnology firms in Malaysia has a significant link in boosting FG. TMS moderates the association between INN and FG, whereas TMI is insignificant. The study has presented findings that confirm the importance of the innovativeness of biotechnology firms. It establishes the role of TMS in strengthening the correlation between innovation and firm growth.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
